Estudio de cohortes sobre la carga socioeconómica de la enfermedad de Parkinson en Portugal

Reese, Jens P; Winter, Y; Rodrigues e Silva, AM; Von Campenhausen, S; Balzer Geldsetzer, M; Oertel, WH; Dodel, R; Sampaio, C; Mateus, C; Freire, R; Rosa, MM; Bötzel, K.
Rev. neurol. (Ed. impr.) ; 52(5): 264-274, 1 mar., 2011. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-87171

Documentos relacionados

  1. Fund Black scientists.
  2. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
  3. Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation.
  4. Costs of Neonatal Intensive Care for Canadian Infants with Preterm Birth.
  5. Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson's disease - the INfusion VErsus STimulation (INVEST) study.
  6. The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years.
  7. Inpatient Profile of Patients with Major Depression in Portuguese National Health System Hospitals, in 2008 and 2013: Variation in a Time of Economic Crisis.
  8. Hospitalization costs in Portugal among people with obesity: results from a nationwide population-based cohort 2011 to 2021.
  9. Surgical outcomes and healthcare expenditures among patients with dementia undergoing major surgery.
  10. Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.